James Levine - 10 Sep 2021 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Financial Officer
Signature
/s/ James Levine
Issuer symbol
CRDF
Transactions as of
10 Sep 2021
Net transactions value
+$194,000
Form type
4
Filing time
13 Sep 2021, 08:12:36 UTC
Previous filing
12 Jul 2021
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $33,100 +5,000 $6.62 5,000 10 Sep 2021 Direct
transaction CRDF Common Stock Purchase $33,750 +5,000 +100% $6.75 10,000 10 Sep 2021 Direct
transaction CRDF Common Stock Purchase $63,800 +10,000 +100% $6.38 20,000 10 Sep 2021 Direct
transaction CRDF Common Stock Purchase $31,750 +5,000 +25% $6.35 25,000 10 Sep 2021 Direct
transaction CRDF Common Stock Purchase $31,600 +5,000 +20% $6.32 30,000 10 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.